about
Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for detecting metastases of Ewing sarcomaThe importance of PET/CT in the evaluation of patients with Ewing tumorsPET imaging in pediatric neuroradiology: current and future applications.Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review.Unusual association of alveolar rhabdomyosarcoma with pancreatic metastasis: emerging role of PET-CT in tumor stagingImaging findings in craniofacial childhood rhabdomyosarcoma.2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcomaUrogenital tumours in childhood.FDG PET/CT imaging of desmoplastic small round cell tumor: findings at staging, during treatment and at follow-up.(99m)Tc-DMSA (V) in Evaluation of Osteosarcoma: Comparative Studies with (18)F-FDG PET/CT in Detection of Primary and Malignant LesionsSerum tumor markers in pediatric osteosarcoma: a summary review.Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.(18)F-FDG PET in sarcoma treatment response imaging.Estimation of potential excess cancer incidence in pediatric 201Tl imaging.New frontiers in pediatric oncologic imagingImproving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives.The role of radiology in paediatric soft tissue sarcomas.Imaging findings in noncraniofacial childhood rhabdomyosarcoma.Solitary relapse of desmoplastic small round cell tumor detected by positron emission tomography/computed tomography.18F-PET-CT in extracranial paediatric oncology: when and for whom is it useful?PET-CT imaging in pediatric oncology.The multidisciplinary management of osteosarcoma.FDG PET imaging of childhood sarcomas.PET/CT in paediatric oncology: indications and pitfalls.Staging of common paediatric tumours.Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.Ewing's sarcoma of proximal phalanx of the hand with skip metastases to metacarpals.(18)F-FDG-PET/CT findings in pancreatic metastasis.Detection of bone metastases in initial staging of orbital embryonal rhabdomyosarcoma by fluorodeoxyglucose positron emission tomography/computed tomographyAskin's Tumor in an Adult: Case Report and Findings on 18F-FDG PET/CT.Value of FDG-PET/CT examinations in different cancers of children, focusing on lymphomas.18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.How could imaging reduce therapy-associated morbidity in rhabdomyosarcoma of the bladder or prostate?Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.Diagnostic value of PET/CT for the staging and restaging of pediatric tumors.Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
P2860
Q24185945-89541AEA-CC47-42B4-9AA1-D77B43A19D79Q26799775-F4B7A754-70A5-4C4F-A82B-826E91C4BF7CQ33516593-2FE9DB6A-73AB-42AA-9096-B8D22872FAD1Q33759995-4B429147-5E16-4384-A156-991A4E0EE306Q33956465-91FA8F33-F3A6-4116-9435-A496ACF5F6F3Q34176966-231C2E54-8562-409A-8314-C0469E910392Q34404416-3A953017-3A02-4539-998C-615748B9C21EQ34706841-465138E0-53EB-46F2-9659-43725F0C09E9Q35697570-05956599-8BE2-4DC1-88A1-31F23E58C04FQ35929022-F3FFC367-FD79-458A-BD9D-55AA52059C5FQ35975003-D7311A8A-EBB7-47F7-886C-01E8E471693EQ35984687-FF9FFB07-A1FF-4C66-BBD7-F3BFC4376D69Q35995816-DC87FCFE-2D28-44C1-9FC9-99F819711048Q36337223-DBC78356-027D-4496-82EB-2504E3E09E8CQ36429326-4A01D624-809B-4568-8EFC-9B37050EECBBQ36573084-8B8FDE6C-E62D-4365-8AEB-D37036DD5C1CQ36623353-3BDE035B-4199-4AAE-ACAB-2DA10C4A03BEQ36627178-80926EEE-88E5-4F6B-BA71-36DFF84D2EEDQ36632585-09B2B128-6917-44B0-8350-76B16AAF05E4Q37119394-EE85CD27-B6A3-45EF-B71C-16D683DA00CEQ37159252-21811003-0293-4361-9612-AB40272DDB1DQ37337261-40BE80EC-BC6A-44CB-9237-9391CEBC95A2Q37400016-67D58DD9-67AA-4960-9D20-DE89974D79E9Q37480204-116F3376-41A1-44E5-BB92-014BDA4A5008Q37480909-0CA23192-6A33-4168-9FFB-4E1114D86E0EQ37480929-921153E9-7D8F-4F75-8E1D-128FBF629A96Q37954566-600B11D5-9E04-4D69-8287-7181C76DDE88Q39413508-65C4817D-8C90-4AE1-8A0F-AEAA543443DCQ41059512-55C3F0D2-924C-4747-A550-9B0C32185B91Q41185495-00AAD7AC-AC77-49F4-9858-D053533E018AQ41491595-B06A0F0F-896D-404C-9EAA-6AAF41728727Q42109690-18F3EA53-F04B-4EAA-A61D-6B0DB6D543C2Q44201482-4BEC6AB1-7134-40CD-AB2B-3726CA1E52FAQ44442401-95A9BCD5-0BD8-4203-849A-55677A5A1B58Q45008408-0A41F6EE-C4A7-44FE-BEB8-5C1946CEC0C9Q46014560-1B100E95-C910-4818-A24C-A6E21371F17FQ46117868-0FBD9607-1E9C-4AC8-A2B2-BE62737CC9E0Q46404566-B3EE5CF8-42F7-43D9-918B-1D96C27D784BQ46416802-88E66E94-B2FD-491C-9FB4-E38FF2C10C61Q46726456-F435F1ED-D508-462E-BEAF-12D3FFD64A02
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
PET/CT in the evaluation of childhood sarcomas.
@ast
PET/CT in the evaluation of childhood sarcomas.
@en
type
label
PET/CT in the evaluation of childhood sarcomas.
@ast
PET/CT in the evaluation of childhood sarcomas.
@en
prefLabel
PET/CT in the evaluation of childhood sarcomas.
@ast
PET/CT in the evaluation of childhood sarcomas.
@en
P2093
P1476
PET/CT in the evaluation of childhood sarcomas.
@en
P2093
M Beth McCarville
Najat C Daw
Ryan Christie
Sheri L Spunt
Sue C Kaste
P304
P356
10.2214/AJR.184.4.01841293
P407
P577
2005-04-01T00:00:00Z